0 items USD 0.00Search
Your search for "Pharma" gave back 90 results.
The Mid-Size Pharmaceutical Market: Market Assessment, Growth Forecasts and Strategic Consolidations for Key Players Summary GBI Research鈥檚 latest...
颁补迟补濒辞驳:听
CBR Pharma Insights
May 2018
Price: USD 2,995.00
Active Pharmaceutical Ingredients (APIs) are active substances in a drug intended to achieve pharmacological activity which is having a direct effect...
颁补迟补濒辞驳:听
IQ4I
March 2021
Price: USD 4,950.00
The report entitled 鈥濧ntibody-Drug Conjugates 2014 鈥� A Business, Technology & Pipeline Analysis鈥� published in January 2014 is based on the...
颁补迟补濒辞驳:听
La Merie Publishing
January 2014
Price: USD 2,298.00
T-Cell & NK-Cell Engaging Bispecific Antibo dies 2019: a business, stakeholder, technology and pipeline analysis report provides you with a...
颁补迟补濒辞驳:听
La Merie Publishing
June 2019
Price: USD 2,700.00
Pharmaceutical excipients are inactive substances in the drug which helps in modulating solubility, bioavailability, and stability of active...
IQ4I
July 2019
Price: USD 4,950.00
The report TCR & CAR Engineered T-Cell and NK Cell Therapeutics 2016: Convergence of technologies opens business opportunities beyond CD19 CARTs...
颁补迟补濒辞驳:听
La Merie Publishing
June 2016
Price: USD 2,750.00
RNA-Targeted Novel Drug Modalities Based on RNA Editing, Epitranscriptomics, Direct RNA Targeting, Splicing Modulation, Translation Regulation,...
颁补迟补濒辞驳:听
La Merie Publishing
November 2022
Price: USD 2,500.00
Cadherins are a family of glycoproteins responsible for calcium ion鈥揹ependent cell adhesion. There are more than 100 types of cadherins in humans,...
颁补迟补濒辞驳:听
La Merie Publishing
May 2022
Price: USD 450.00
Claudin 6 (CLDN6) is a compelling tumor antigen. The tetraspan membrane protein is a member of the claudin family of tight junction proteins. CLDN6...
颁补迟补濒辞驳:听
La Merie Publishing
May 2022
Price: USD 560.00
This report evaluates G-protein鈥揷oupled receptor family C group 5 member D (GPRC5D) from an industry perspective for its suitability as a tumor-...
颁补迟补濒辞驳:听
La Merie Publishing
July 2022
Price: USD 670.00
This report provides you with a landscape description and analysis of discovery and development of claudin 18.2 (CLDN18.2)-targeted antibody and cell...
颁补迟补濒辞驳:听
La Merie Publishing
August 2023
Price: USD 2,365.00
This report provides a landscape description and analysis of chimeric antigen receptor-macrophage (CAR-M) platform technologies and stakeholders from...
颁补迟补濒辞驳:听
La Merie Publishing
February 2023
Price: USD 2,000.00
Global Clinical Trials - Current Trends and Recent Advancement Summary GBI Research鈥檚 latest report, Global Clinical Trials - Current Trends and...
颁补迟补濒辞驳:听
CBR Pharma Insights
January 2019
Price: USD 2,995.00
Report Package: Bispecific Antibodies This report package includes the full report T-Cell & NK-Cell Engaging Bispecific Antibodies 2019: a...
颁补迟补濒辞驳:听
La Merie Publishing
July 2019
Price: USD 2,840.00
Over the last two decades, the Pharmaceutical industry has seen a radical change. The unprecedented downsizing of the internal discovery of big...
颁补迟补濒辞驳:听
IQ4I
May 2021
Price: USD 7,200.00
听
